Pegylated interferon α-2a plus ribavirin for decompensated hepatitis C virus-related cirrhosis: relationship between efficacy and cumulative dose
Author:
Affiliation:
1. Department of Digestive; China-Japan Union Hospital affiliated to Jilin University; Changchun China
Funder
National Natural Science Foundation of China
Publisher
Wiley
Subject
Hepatology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/liv.12417/fullpdf
Reference30 articles.
1. Association between the treatment length and cumulative dose of pegylated interferon alpha-2b plus ribavirin and their effectiveness as a combination treatment for Japanese chronic hepatitis C patients: project of the Kyushu University Liver Disease Study Group;Furusyo;J Gastroenterol Hepatol,2008
2. Advancement in the development of models for hepatitis C research;Carcamo;J Biomed Biotechnol,2012
3. Natural history of hepatitis C;Thomas;Clin Liver Dis,2005
4. Diagnosis, management, and treatment of hepatitis C;Strader;Hepatology,2004
5. Prognosis of chronic hepatitis C: results of a large, prospective cohort study;Niederau;Hepatology,1998
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Outcomes of direct-acting antivirals in patients with HCV decompensated cirrhosis: a systematic review and meta-analysis;Frontiers in Medicine;2023-11-29
2. Outcomes of Interferon-free Direct Acting Antivirals in Patients with HCV-related Decompensated Cirrhosis: A Systematic Review and Meta-analysis;2023-04-12
3. Management of hepatitis C virus infection in the Asia-Pacific region: an update;The Lancet Gastroenterology & Hepatology;2017-01
4. IMPACT OF THE PEGYLATED-INTERFERON AND RIBAVIRIN THERAPY ON THE TREATMENT-RELATED MORTALITY OF PATIENTS WITH CIRRHOSIS DUE TO HEPATITIS C VIRUS;Revista do Instituto de Medicina Tropical de São Paulo;2016
5. Direct antiviral agent treatment of decompensated hepatitis C virus-induced liver cirrhosis;World Journal of Gastrointestinal Pharmacology and Therapeutics;2015
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3